RANTES/CCL5 Protein, Human HY-P70450 from MedChemExpress

Product Specs
ItemRANTES/CCL5 Protein, Human
CompanyMedChemExpress
Price $280.00Supplier Page View Company Product Page
Catalog NumberHY-P70450
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
TypeProtein
Size50 µg
Molecular Weight7-12 kDa
Source/Expression SystemE. coli
ActivityFully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human peripheral blood monocytes is in a concentration range of 1.0-10.0 ng/mL
SpeciesHuman
NCBI Full Gene NameC-C motif chemokine ligand 5
NCBI Gene AliasesSIS-delta, D17S136E, SISd, TCP228, RANTES, SCYA5, eoCP

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

(1) Tumor-associated macrophage-derived chemokine ligand 5 regulates the Hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway to promote breast cancer invasion and migrationCytojournalApril 17, 2026Yongyun Zhu, Mingxiang Zhang, Zhengzhi Zhudivided into three groups: control, CCL5 (20 ng/mL), and CCL5 (40 ng/mL). The concentrations of CCL5 (HY-P70450, MedChemExpress, New Jersey, USA) were selected on the basis of the authors’ previous reports.[19,21]

(2) Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1α/ZEB1 axisCell death & diseaseMay 20, 2022Xu H, Zhao J, Li J, Zhu Z, Cui Z, Liu R, Lu R, Yao Z, Xu Q.cells onto 6-well plates at the density of 2 × 105 cells/well. For CCL5 stimulation in vitro, hCCL5 (HY-P70450, MedChemExpress, New Jersey, USA) in medium at the concentration of 20 ng/ml and 100 ng/ml for incubating

(4) RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathwayBiology openSeptember 26, 2014Maillard L, Saito N, Hlawaty H, Friand V, Suffee N, Chmilewsky F, Haddad O, Laguillier C, Guyot E, Ueyama T, et al.

(5) RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycansAngiogenesisDecember 1, 2012Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, Martin L, Laguillier C, Richard B, Oudar O, et al.

(7) CCL5 and CCR5 interaction promotes cell motility in human osteosarcomaPloS oneJanuary 1, 2012Wang SW, Wu HH, Liu SC, Wang PC, Ou WC, Chou WY, Shen YS, Tang CH.

(8) Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS dataStructure (London, England : 1993)August 10, 2011Wang X, Watson C, Sharp JS, Handel TM, Prestegard JH.

(9) RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway diseaseEuropean journal of immunologyNovember 1, 2002Tekkanat KK, Maassab H, Miller A, Berlin AA, Kunkel SL, Lukacs NW.

RANTES/CCL5 Protein, Human from MedChemExpress